Atlas Trials

The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery

Clinical trial NCT00350519 · TERMINATED

Trial details

NCT number
NCT00350519
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Hemostasis, Surgical
Start date
2006-08-01
Primary completion
2008-02-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.